Announcements

28 February 2026
MDPI INSIGHTS: The CEO’s Letter #32 - MDPI China and Thailand, China Science Daily, 1,000 Partnerships, R2R

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflections from China: Year-End-Celebrations and Open Access Publishing

In February, I had the pleasure of joining over a thousand colleagues from our Tongzhou and Haidian offices at their end-of-year annual celebration in Beijing.

Spending time with our teams in China is also a powerful reminder of the scale and complexity of MDPI as a global organization. Our colleagues in Beijing, Wuhan, and across the country play a significant role in our day-to-day operations and long-term development. I’m grateful for the hospitality, collaboration, and commitment shown by our managers and teams in China, alongside colleagues worldwide, who have helped steadily build MDPI, brick by brick, over the years.

Below are some data on Open Access (OA) publishing in China and our collaboration in this important research market.

Open Access Publishing in China

China has been the world’s leading country in research and review article publication volume since 2019, exceeding one million publications in 2025. Over the past five years, the gap between China and the second-ranked country, the United States, has continued to widen.

In 2025:

  • 47% of China’s research output was published Open Access
  • Of those OA publications, 76% were Gold Open Access (approximately 382,930 articles)
  • The overall OA distribution remained stable compared with 2024, with Gold OA increasing by 1%

Over the past five years (2021–2025):

  • China published 4,398,050 research and review articles
  • Approximately 48% of this output was OA

According to Dimensions, when comparing the top 20 countries by publication volume (2021–2025):

  • China ranks 1st worldwide in publication volume
  • China ranks 9th in citation performance within this group (for comparison, the US ranks 2nd in publication volume and 10th in citation ranking)
  • Average citations per article: 12.51

Among the top 10 universities globally by publication volume, six are Chinese institutions, alongside Harvard University (USA), the University of São Paulo (Brazil), the University of Toronto (Canada), and the University of Oxford (UK).

MDPI and China

China is an important and long-standing part of MDPI’s global publishing ecosystem:

  • In 2025, MDPI was the largest fully Open Access publisher in China
  • MDPI published 22% of China’s Gold Open Access output (82,133 papers)
  • We received 290,999 submissions from China-affiliated authors and published 82,133 articles
  • There are 8,500+ active Editorial Board Members based in China
    • 64% (5,438) have an H-index above 26
  • MDPI works with:
    • 117 Editors-in-Chief
    • 103 Section Editors-in-Chief
  • 71 China-based institutions currently hold IOAP agreements with MDPI, seven of which rank among the top 10 Chinese institutions by publication volume

China's scale in research output means that the publishing platforms chosen by Chinese scholars will continue to influence the direction of scholarly publishing. At the same time, MDPI’s strength comes from its international collaboration, with colleagues, editors, reviewers, and authors working together across regions and disciplines.

Thank you to all our colleagues in China, and around the world, who support MDPI’s publishing activities across departments and help advance open access research every day.

Impactful Research

“Progress in open science is built through trust, dialogue, and relationships”

Behind the Scenes: A Conversation with China Science Daily

During my trip to Beijing, I also had the opportunity to visit China Science Daily and take part in an interview and broader exchange with their team in Beijing. Visits like this matter because progress in open science is built not only through platforms and infrastructure, but also through trust, dialogue, and relationships across research communities and regions.

China Science Daily: History Museum

As part of the visit, I was given a tour of their History Museum, which offers a thorough perspective on the evolution of China’s first science and technology newspaper, established in 1959. The exhibition highlights how the organization developed into a trusted institution connecting research with the public and policymakers. It was a helpful reminder that at the core of publishing is stewardship, credibility, and long-term public engagement with science.

An Open Exchange on Open Science

During the visit, I met with Dr. Zhao Yan, Editor-in-Chief of ScienceNet. We had an open and engaging conversation about MDPI’s role in Open Access, the evolution of open science globally, and the potential for more collaboration going forward. He especially appreciated the candid and personal nature of our exchange, noting that this kind of dialogue feels important in a landscape where trust and transparency matter.

Interview on Open Access

I also participated in an interview with Ms. Yan Jie, from the Online Media Center and Editor-in-Chief of ScienceNet, China Science Daily. Our discussion covered the growth of Open Access over the past 30 years, MDPI’s mission and values, academic integrity, collaboration with the Chinese research community, and MDPI’s own 30th anniversary milestone. It was a great opportunity to reflect on how open science has matured, and where shared responsibility across publishers, institutions, and researchers continues to matter most.

“Progress in open science is built by more than scale and infrastructure”

I’m sharing a few photos from the visit as a glimpse behind the scenes. The full interview will be published by China Science Daily in due course, and I look forward to sharing it when it is available.

More broadly, visits like this reinforce something I’ve always believed in: progress in open science is built not only through scale and infrastructure, but also through continued dialogue, mutual respect, collaboration, and a willingness to listen across regions and perspectives. That remains central to our work, especially as MDPI reflects on 30 years of publishing, built together.

Inside MDPI

Bangkok Visit: Growth, Partnership, and Local Impact

In February, I also had the opportunity to visit our Bangkok office for the second time in two years to support their local meetings and deliver a training session on how we present MDPI at a corporate level.

It’s easy to spend time with our colleagues in Thailand. From Editorial and Production to Conferences, Marketing, Design, and our Regional Journal Relations Specialist (RJRS), the team continues to grow in scale and professionalism. I’d also like to recognize our local management and admin teams, who have been steadily expanding our office and supporting more than 500 colleagues on the ground.

Academic Partnerships

During the visit, we met with the Engineering Department at King Mongkut’s Institute of Technology Ladkrabang (KMITL). Our discussion focused on the recent MDPI developments, Institutional Open Access Program (IOAP) opportunities, Author Publishing Workshops (APW), and the potential use of JAMS to support their institutional journal.

“MDPI is the third-largest OA publisher in Thailand”

We also shared insights into the growth of Open Access (OA) in Thailand and KMITL’s own publishing trends. These conversations matter because institutions are looking for sustainable ways to support their researchers. Our IOAP agreements are one simple example of how we can provide value in this area while maintaining accessibility for authors.

Thailand and MDPI: 2025 Snapshot

Our Bangkok office, officially launched in 2022, has been growing to support over 500 staff members while continuing to expand its engagement in scholar visits, workshops, and conference collaborations. As at 2025, Thailand submissions to MDPI have increased about 21% and publications by about 25%, maintaining a rejection rate close to the company average. MDPI is the third-largest OA publisher in Thailand, publishing 15% of all Gold OA output in 2025.

Representing MDPI Externally

During the visit, I delivered a training session on how we present MDPI at external events.

This session covered topics related to:

  • Our aim and guiding principles
  • High-level company milestones and Indexing facts and figures
  • Industry partnerships and collaborations
  • Market trends in OA and subscription publishing
  • Country-specific publishing data and collaborations with MDPI
  • Insights from our Voice of Community report

I find that while many colleagues are very familiar with the specific journal for which they have responsibility, fewer have visibility into the broader MDPI ecosystem and the company’s global positioning. These sessions help build alignment, confidence, and consistency in how we represent the company.

What stands out most is that MDPI’s growth is not abstract: it’s visible in the people, the partnerships, and the professionalism developing across our offices.

Coming Together for Science

1,000 Institutional Partners: A Milestone Built on Trust

This month, we reached an important milestone: more than 1,000 institutions worldwide are now part of MDPI’s Institutional Open Access Program (IOAP). On paper, that is a number. In practice, it represents trust.

This milestone symbolizes thousands of conversations with libraries and institutions. It stands for negotiations, renewals, consortium expansions, and, most importantly, relationships built over time. It reflects the work of colleagues across publishing, institutional partnerships, marketing, editorial, finance, and many other teams who contribute to making these agreements operational.

In 2025 alone, more than 61,300 research articles benefited from article processing charge (APC) discounts through IOAP agreements. Tens of thousands of authors were able to publish through a simplified and structured process. At the same time, institutional administrators gained clearer oversight and streamlined workflows.

Why IOAP Matters

When we launched IOAP, the objective was straightforward: to reduce barriers for researchers while supporting institutions in navigating the evolving OA landscape. Over the past decade, the research ecosystem has changed. Funder mandates, national policies, and Plan S–aligned requirements have accelerated the transition to OA.

Institutions need publishing partners who provide transparency, scalability, and operational efficiency. IOAP was designed to support that reality.

For colleagues who would like to better understand the program, this blog-post overview of MDPI’s IOAP provides additional context, including common questions around the transition to OA and how our institutional partnerships are structured.

“Institutions need publishing partners who provide transparency, scalability, and operational efficiency”

Recent Examples

Our agreements continue to evolve across regions:

These examples show that institutions seek structured, predictable models that support their researchers at scale.

Looking Ahead

Crossing the threshold of 1,000 partners tells us that institutions see MDPI not just as a publisher but as a reliable operational partner in advancing open science. This milestone is not a finish line. It is a reminder that the work continues.

Thank you to the entire IOAP team and to all colleagues who contributed to reaching this achievement.

P.S. You can read about this milestone across industry outlets, including STM Publishing News, ALPSP, Research Information, EurekAlert, Brightsurf, among others. You can also read about the coverage in Poland (e.g., media-room, bomega) Korea (newstap), and Romania (EduLike).

Closing Thoughts

Reflections from the Researcher to Reader Conference

During 24–25 February, I attended the 2026 Researcher to Reader Conference in London, UK. Leaders from across scholarly publishing, research infrastructure, libraries, and technology gathered to discuss AI and research integrity, peer review reform, metadata and infrastructure, community engagement, open research policy, and the evolving role of publishers in a rapidly shifting ecosystem.

The conversations were open and honest, and at times uncomfortable – exactly what we need at times. Below are a few reflections that stayed with me.

The Battle for Knowledge: What Becomes Accepted as ‘True’?

One recurring theme was not whether science evolves but whether our infrastructure is resilient enough to sustain trust at scale. Science does not promise certainty: it promises process. As publishing systems grow more complex and become more technologically mediated, the question is how intentionally we design, monitor, and strengthen that process.

Peer Review: Speed, Credentials, and Structural Loops

Researchers consistently call for faster peer review. At the same time, reviewer credentials are often tied to publication records. This creates a structural loop. Publishing history opens reviewing opportunities, reviewing strengthens credentials, and those without early access remain outside the cycle.

There is a need for us to reflect on how opportunity circulates within our systems: we should ask how we create more inclusive pathways for researchers globally to participate in peer review.

Community Engagement Workshop

One of the highlights of R2R was the workshop format, whereby small groups met repeatedly over two days and moved from ideas to tangible strategies.

I joined the Community Engagement workshop led by Lou Peck (CEO at The International Bunch) and Godwyns Onwuchekwa (Principal Consultant at Global Tapestry Consulting). We explored two deceptively simple questions: What is a community? and What does engagement truly mean?

“Engagement requires shared design and shared responsibility”

Too often, organizations equate communication with engagement. The framework discussed mapped a maturity spectrum – from enablement (broadcasting, informing and consulting) to true engagement (collaborating and co-creating).

It was a useful reminder of the fact that if we want trust and loyalty, engagement must go beyond announcements and surveys. It requires shared design and shared responsibility.

AI: Democratization or Digital Colonialism?

I especially enjoyed the thought-provoking presentation from Nikesh Gosalia (Chief Partnership Officer at Cactus Communications), which highlighted an uncomfortable reality:

  • 93% of AI-generated content is in English
  • Approximately 2% is in French
  • Approximately 2% is in German
  • More than 7,000 languages are represented in less than 5% of the content within large AI systems

The implications are profound. Is AI democratizing access to scholarly publishing (making it easier for researchers everywhere to participate in global knowledge production)? Or are we encoding colonialism at scale (entrenching linguistic and structural hierarchies, and making it harder for voices from the Global South to be heard)?

AI is already reshaping how research is created, reviewed, discovered, and shared. Its potential is enormous. But its impact depends not only on capability, but on governance, design, and intentionality. Publishers, funders, and researchers all share responsibility in shaping how these systems evolve.

Ethicality in practice (Lightening Talk)

It was also great to have our colleague Dr Miloš Čučulović (Head of Technology Innovation at MDPI) present MDPI’s Ethicality platform during a lightning talk.

“Technology alone is not the answer”

Ethicality embeds AI-driven checks directly into the submission workflow, supporting editors proactively rather than reacting after publication. As we scale, tools like this help balance trust, efficiency, and research integrity.

This goes back into the underlying theme of the conference that technology alone is not the answer. However, technology embedded thoughtfully within clear governance frameworks can strengthen confidence in the editorial process.

Final thought

The question is no longer whether technology will transform research infrastructure: it is already doing so. The real question is what role each of us will play in shaping that transformation deliberately, with structural maturity, inclusive governance, and engagement that moves from informing to co-creating.

Science needs to evolve, responsibly. And that responsibility extends not only to what we publish, but also to how the systems behind publication are designed. Some important topics to continue reflecting on both internally and within our broader community.

Stefan Tochev
Chief Executive Officer
MDPI AG

20 February 2026
MDPI Virtual Academic Publishing Workshop (New Harvest), 25 February 2026


This Academic Publishing Workshop will be led by MDPI Regional Journal Relations Specialist, Dr. Sally Wu, on “Author Training”. Participants will receive practical advice on essential aspects of writing academic articles. Participants will leave with a clearer understanding of the academic publishing landscape and how to successfully contribute to it.

Date: 25 February 2026
Time: 11:30 a.m.–1:30 p.m. EST

Schedule:

Speaker

Program

Time in EST

Dr. Sally Wu

Introduction

11:30–11:40 a.m.

Dr. Sally Wu

Tips for Writing Great Research Papers

  • Structuring a research paper
  • Tips for every section of a research paper
  • Q&A Session

11:40 a.m.–12:15 p.m.

Dr. Sally Wu

How to Respond to Peer Reviewers

  • Peer Review Reports
  • Examples of Response to Reviewers
  • Q&A Session

12:15–12:50 p.m.

Dr. Sally Wu

AI in Publishing: Challenges and Opportunities

  • AI in scientific publishing
  • How to use AI ethically
  • Q&A Session

12:50–13:30 p.m.

Speakers:

Dr. Sally Wu received a PhD in medical science from the University of Toronto in the fall of 2025. She joined MDPI in February 2025 as an Assistant Editor for Cells. She was recently promoted to Regional Journal Relations Specialist position in August. In this role, she works with many journals, liaising with authors, board members, and EiCs. She has attended several conferences across North America, hosted scholar visits, and taken part in other outreach events.

20 February 2026
Biosensors | Collection of Title Stories in 2025


1.
“A Microfluidic Paper-Based Device for Monitoring Urease Activity in Saliva”
by António O. S. S. Rangel, Francisca T. S. M. Ferreira and Raquel B. R. Mesquita
Biosensors 2025, 15(1), 48; https://doi.org/10.3390/bios15010048
Available online: https://www.mdpi.com/2079-6374/15/1/48 

2. “Innovative Molecular Imprinting Sensor for Quick, Non-Invasive Cortisol Monitoring in Fish Welfare”
by Daniela Santos Oliveira, Felismina T. C. Moreira and Hugo G. Santos
Biosensors 2025, 15(4), 204; https://doi.org/10.3390/bios15040204
Available online: https://www.mdpi.com/2079-6374/15/4/204 

3. “A Facile Surface Modification Strategy for Antibody Immobilization on 3D-Printed Surfaces”
by Brandi Binkley and Peng Li
Biosensors 2025, 15(4), 211; https://doi.org/10.3390/bios15040211
Available online: https://www.mdpi.com/2079-6374/15/4/211

4. “Recent Advances of Fluorescent Aptasensors for the Detection of Antibiotics in Food”
by Chunyan Sun, Huikai Lin, Mingdi Zhang, Wenyi Yang and Zheng Liu
Biosensors 2025, 15(4), 252; https://doi.org/10.3390/bios15040252
Available online: https://www.mdpi.com/2079-6374/15/4/252

5. “One-Pot Colorimetric Nucleic Acid Test Mediated by Silver Nanoparticles for DNA Extraction and Detection”
by Kieu The Loan Trinh, Nae Yoon Lee and Seung Kyun Park
Biosensors 2025, 15(5), 271; https://doi.org/10.3390/bios15050271
Available online: https://www.mdpi.com/2079-6374/15/5/271

6. “Understanding the Mechanism of Bent DNA Amplifying Sensors Using All-Atom Molecular Dynamics Simulations”
by Asmaa A. Sadoon, Deborah Okyere, Jiali Li, Jingyi Chen, Kaitlin Bullard, Shelbi J. Foster and Yong Wang
Biosensors 2025, 15(5), 272; https://doi.org/10.3390/bios15050272
Available online: https://www.mdpi.com/2079-6374/15/5/272 

7. “Rapid and Highly Sensitive Detection of Ricin in Biological Fluids Using Optical Modulation Biosensing”
by Amos Danielli, Efi Makdasi, Eliana Levy, Linoy Golani-Zaidie, Ofir Schuster, Reut Falach, Ron Alcalay and Shmuel Burg
Biosensors 2025, 15(5), 295; https://doi.org/10.3390/bios15050295
Available online: https://www.mdpi.com/2079-6374/15/5/295

8. “Non-Enzymatic Selective Detection of Histamine in Fishery Product Samples on Boron-Doped Diamond Electrodes”
by Hiroshi Aoki, Risa Miyazaki and Yasuaki Einaga
Biosensors 2025, 15(8), 489; https://doi.org/10.3390/bios15080489
Available online: https://www.mdpi.com/2079-6374/15/8/489 

9. “Cutting-Edge Sensor Technologies for Exosome Detection: Reviewing Role of Antibodies and Aptamers”
by Guozhen Liu and Sumedha Nitin Prabhu
Biosensors 2025, 15(8), 511; https://doi.org/10.3390/bios15080511
Available online: https://www.mdpi.com/2079-6374/15/8/511

10. “Cell Observation and Analysis with a Three-Dimensional Optical Wave Field Microscope”
by Junta Minato, Kosuke Kusamori, Mai Kanai, Makiya Nishikawa, Masahiro Hashimoto, Masaki Kobayashi, Shimon Matsumoto, Shoko Itakura and Shu Obana
Biosensors 2025, 15(8), 515; https://doi.org/10.3390/bios15080515
Available online: https://www.mdpi.com/2079-6374/15/8/515 

11. “Smartphone-Integrated Electrochemical Devices for Contaminant Monitoring in Agriculture and Food: A Review”
by Seyed Mohammad Taghi Gharibzahedi and Sumeyra Savas
Biosensors 2025, 15(9), 574; https://doi.org/10.3390/bios15090574
Available online: https://www.mdpi.com/2079-6374/15/9/574

12. “Graphene-Based Biosensors: Enabling the Next Generation of Diagnostic Technologies—A Review”
by John Paolo Ramoso, Manoochehr Rasekh and Wamadeva Balachandran
Biosensors 2025, 15(9), 586; https://doi.org/10.3390/bios15090586
Available online: https://www.mdpi.com/2079-6374/15/9/586

13. “PEI-FeO/PTA-AuNPs Hybrid System for Rapid DNA Extraction and Colorimetric LAMP Detection of E. faecium
by Haang Seok Choi, Muniyandi Maruthupandi and Nae Yoon Lee
Biosensors 2025, 15(9), 601; https://doi.org/10.3390/bios15090601
Available online: https://www.mdpi.com/2079-6374/15/9/601

14. “Decoding Molecular Network Dynamics in Cells: Advances in Multiplexed Live Imaging of Fluorescent Biosensors”
by Qiaowen Chen, Yichu Xu, Jhen-Wei Wu, Jr-Ming Yang and Chuan-Hsiang Huang
Biosensors 2025, 15(9), 614; https://doi.org/10.3390/bios15090614
Available online: https://www.mdpi.com/2079-6374/15/9/614

 

18 February 2026
MDPI’s Open Access Program Reaches 1,000 Institutions Worldwide

MDPI has surpassed the milestone of 1,000 partners within the Institutional Open Access Program (IOAP). The agreements span 59 countries, covering North and South America, Europe, Asia, Africa, and Oceania.

Last year alone, more than 150 new libraries and academic institutions joined MDPI’s IOAP. With the expansion of an existing consortium deal in Sweden we welcomed a further 75 partners to the program in January 2026, enabling us to surpass the 1,000-partners milestone.

The IOAP supports affiliated researchers by streamlining submission processes, reducing administrative burdens, and offering discounted Article Processing Charges (APCs). Through IOAP membership, more than 61,300 research articles received APC discounts in 2025, driving greater visibility and accessibility for partner institutions and global research communities alike.

"This milestone marks a significant step towards expanding MDPI’s global impact," said Stefan Tochev, MDPI's CEO. "Reaching 1,000 IOAP partnerships is a true testament to the growing trust and collaboration we’ve built with universities, libraries, and research organizations worldwide. We are proud to lead the way in Open Access publishing, ensuring researchers have the support they need to reach global audiences." "The success of our program is reflected in the growing global demand for Open Science and quality publishing services," said Becky Castellon, MDPI institutional partnerships manager. "Equally, institutions are increasingly seeking Open Access publishing options that support funder and national mandates. Joining the IOAP makes compliance simple."

11 February 2026
MDPI Webinar | World Cancer Day, 12 February 2026


To commemorate World Cancer Day 2026, MDPI is delighted to introduce the “World Cancer Day 2026 Webinar Series”. Reflecting the global theme “United by Unique,” this series reminds us that each story, discovery, and voice plays a vital role in strengthening the world’s collective fight against cancer.

Kicking off with our February session, this first installment welcomes leading voices in oncology to share impactful insights, raise awareness, and spotlight breakthrough research.

Through this series, we aim to empower the global community with knowledge, inspire collaboration, and support ongoing efforts in cancer prevention, diagnosis, and treatment.

Together, we will honor every patient’s journey, elevate the contributions of researchers, and reinforce the power of collective action in the fight against cancer.

Date: 12 February 2026
Time: 6:00 p.m. CET | 12:00 p.m. EST | 1:00 a.m. CST (Asia)
Webinar ID: 899 8080 6135
Webinar Secretariat: journal.webinar@mdpi.com

Register now for free!

Program:

Speaker and Presentation Title Time in CET Time in EST
Introduction 6:00–6:10 p.m. 12:00–12:10 p.m.
Dr. Xiang Xue
PINK1 Deficiency Facilitates Mitochondrial Iron Accumulation and Colon Tumorigenesis
6:10–6:30 p.m. 12:10–12:30 p.m.
Dr. Federico Pio Fabrizio
Epigenetics of KEAP1/NRF2 Signaling: From Molecular Mechanisms to Clinical Implications
6:30–6:50 p.m. 12:30–12:50 p.m.
Dr. Anis Ahmad
Protecting Healthy Organs While Treating Cancer: New Molecular Strategies to Improve Survivorship
6:50–7:10 p.m. 12:50–1:10 p.m.
Dr. Hiroaki Kiyokawa
Stabilizing Tumor Suppressors: Therapeutic Frontiers in Precision Medicine
7:10–7:30 p.m. 1:10–1:30 p.m.
Q&A Session 7:30–7:55 p.m. 1:30–1:55 p.m.
Closing of Webinar 7:55–8:00 p.m. 1:55–2:00 p.m.

After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.

Webinar Keynote Speakers:

  • Dr. Xiang Xue, Department of Biochemistry and Molecular Biology, School of Medicine, University of New Mexico, USA;
  • Dr. Federico Pio Fabrizio, Department of Medicine and Surgery, Faculty of Medicine, Kore University of Enna, Italy;
  • Dr. Anis Ahmad, Department of Radiation Oncology, Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, USA;
  • Dr. Hiroaki Kiyokawa, Department of Pharmacology, Feinberg School of Medicine, Northwestern University, USA.

4 February 2026
Biosensors | Issue Cover Articles in 2025


The articles below have been selected as the 2025 Issue Cover Articles by the Editorial Office of Biosensors (ISSN: 2079-6374). These articles come from multiple fields within the scope of Biosensors. We hope that they can provide insights and references for scholars in these fields.

1. “A Truncated Multi-Thiol Aptamer-Based SARS-CoV-2 Electrochemical Biosensor: Towards Variant-Specific Point-of-Care Detection with Optimized Fabrication”
by Andreas Offenhäusser, Dirk Mayer, Ferdinando Catania, Gabriela Figueroa-Miranda, Kevin Graef, Martin Rabe, Mateo Alejandro Martínez-Roque, Nafiseh Samiseresht and Sergio Roberto Molina Ramirez
Biosensors 2025, 15(1), 24; https://doi.org/10.3390/bios15010024
Available online: https://www.mdpi.com/2079-6374/15/1/24

2. “Parallel Detection of the Unamplified Carbapenem Resistance Genes blaNDM-1 and blaOXA-1 Using a Plasmonic Nano-Biosensor with a Field-Portable DNA Extraction Method”
by Evangelyn C. Alocilja and Kaily Kao
Biosensors 2025, 15(2), 112; https://doi.org/10.3390/bios15020112
Available online: https://www.mdpi.com/2079-6374/15/2/112

3. “An Antimicrobial and Antifibrotic Coating for Implantable Biosensors”
by Alican Ozkan, Arash Naziripour, Badrinath Jagannath, Donald E. Ingber, Henrik Bengtsson, Nandhinee Radha Shanmugam, Pawan Jolly, Pranav Prabhala, Rohini Singh, Sofia Wareham-Mathiassen et al.
Biosensors 2025, 15(3), 171; https://doi.org/10.3390/bios15030171
Available online: https://www.mdpi.com/2079-6374/15/3/171

4. “Stamp-Imprinted Polymer EIS Biosensor for Amyloid-Beta Detection: A Novel Approach Towards Alzheimer’s Screening”
by Chloé E. D. Davidson and Ravi Prakash
Biosensors 2025, 15(4), 228; https://doi.org/10.3390/bios15040228
Available online: https://www.mdpi.com/2079-6374/15/4/228

5. “Unraveling Charge Transfer Mechanisms in Graphene–Quantum Dot Hybrids for High-Sensitivity Biosensing”
by Hugo Sanabria, Ramakrishna Podila and Shinto Mundackal Francis
Biosensors 2025, 15(5), 269; https://doi.org/10.3390/bios15050269
Available online: https://www.mdpi.com/2079-6374/15/5/269

6. “Multiplexed CRISPR Assay for Amplification-Free Detection of miRNAs”
by Breno S. Diniz, David C. Steffens, Hansana Gunathilaka, Islam M. Mosa, James F. Rusling, Jessica L. Rouge, Keshani Hiniduma, Ketki S. Bhalerao, Kevin Manning, P. I. Thilini De Silva et al.
Biosensors 2025, 15(6), 346; https://doi.org/10.3390/bios15060346
Available online: https://www.mdpi.com/2079-6374/15/6/346

7. “Labeled Bovine Serum Albumin as a Fluorescent Biosensor to Monitor the Stability of Lipid-Based Formulations”
by Barbara Campanini, Luca Ronda, Marianlaura Marchetti, Omar De Bei, Serena Faggiano, Stefania Bova, Stefano Bettati and Stefano Bruno
Biosensors 2025, 15(7), 425; https://doi.org/10.3390/bios15070425
Available online: https://www.mdpi.com/2079-6374/15/7/425

8. “Wearable Personal Uroflowmeter for Measuring Urine Leakage in Women with Incontinence: Feasibility Study”
by Ali Attari, Carol Day, Faezeh Shanehsazzadeh, James A. Ashton-Miller, John O. L. DeLancey and Tana Kirkbride
Biosensors 2025, 15(8), 481; https://doi.org/10.3390/bios15080481
Available online: https://www.mdpi.com/2079-6374/15/8/481

9. “Robust Pt/Au Composite Nanostructures for Abiotic Glucose Sensing”
by Asghar Niyazi, Ashley Linden and Mirella Di Lorenzo
Biosensors 2025, 15(9), 588; https://doi.org/10.3390/bios15090588
Available online: https://www.mdpi.com/2079-6374/15/9/588

10. “Application of the Combined QCM-D/LSPR Aptasensor for Penicillin G Detection”
by Andrea Csaki, Katrin Wondraczek, Kiran Sontakke, Lukas Dubbert, Matthias Urban, Sandro Spagnolo, Tibor Hianik, Tomas Lednicky and Wolfgang Fritzsche
Biosensors 2025, 15(10), 652; https://doi.org/10.3390/bios15100652
Available online: https://www.mdpi.com/2079-6374/15/10/652

11. “Microfluidic-Integrated, Ring-Resonator-Assisted Mach–Zehnder Interferometer (μFRA-MZI) as a Label-Free Nanophotonic Sensor”
by Ethan Glenn Seutter, Jiandi Wan, Yunju Chang and Zihao Wang
Biosensors 2025, 15(11), 741; https://doi.org/10.3390/bios15110741
Available online: https://www.mdpi.com/2079-6374/15/11/741

12. “Size Effects of Silver Nanoparticles and Magnetic Beads on Silver-Gold Galvanic Exchange in Aptamer-Based Electrochemical Assays”
by Charuksha Walgama, Daniel Adrian, Eman Alwarsh, Marco Cardenas and Trang Bui
Biosensors 2025, 15(12), 768; https://doi.org/10.3390/bios15120768
Available online: https://www.mdpi.com/2079-6374/15/12/768

3 February 2026
World Cancer Day—“United by Unique”, 4 February 2026


World Cancer Day draws global attention to the ongoing fight against cancer—one of the leading causes of morbidity and mortality worldwide. Observed annually on 4 February, World Cancer Day unites individuals, communities, researchers, clinicians, and policymakers in a shared commitment to reduce the global cancer burden and improve outcomes for patients everywhere.

Aligned with this year’s theme and the United Nations Sustainable Development Goal 3 (Good Health and Well-Being), the initiative calls for greater awareness, early detection, equitable access to care, and sustained investment in cancer research and innovation. From prevention and diagnosis to treatment and survivorship, addressing cancer requires coordinated, multidisciplinary efforts across healthcare systems and scientific communities worldwide.

In support of World Cancer Day, selected MDPI journals highlight cutting-edge research across the cancer continuum, including advances in oncology, diagnostics, therapeutics, public health, and patient-centred care. Through curated articles, Special Issues, and expert-led webinars, these journals aim to foster knowledge exchange and collaboration to accelerate progress toward a future where cancer prevention and treatment are accessible, effective, and equitable for all.

In 2026, MDPI is honored to support World Cancer Day through a monthly awareness ries beginning in February. Each session will focus on a key cancer awareness theme, showcasing cutting-edge research and expert insights through specially curated landing pages and a dedicated webinar series. Through this special activity, we aim to sustain engagement and cross-disciplinary collaboration throughout the year. Below is the list of events. You may click on the respective links (updated throughout the year, closer to each event month) to access the individual event pages.

Month Relevant Cancer Awareness Month
January Cervical Cancer Awareness Month
February World Cancer Day
March Colorectal Cancer Awareness Month
April Esophageal Cancer Awareness Month
May Bladder Cancer Awareness Month
June Cancer Survivorship Awareness Month
July Sarcoma and Bone Cancer Awareness Month
August Brain Cancer Awareness Month
September Childhood Cancer Awareness Month
October Breast Cancer Awareness Month
November Lung Cancer Awareness Month
December Skin Cancer Awareness Month


Keynote Speakers

Dr. Xiang Xue,
University of New Mexico, USA

Dr. Federico Pio Fabrizio,
Kore University of Enna, Italy

Dr. Anis Ahmad,
University of Miami, USA

Dr. Hiroaki Kiyokawa,
Northwestern University, USA

Register for this webinar for free here!

 

Molecular Insight and Antioxidative Therapeutic Potentials of Plant-Derived Compounds in Breast Cancer Treatment
by Sandhya Shukla, Arvind Kumar Shukla, Adarsha Mahendra Upadhyay, Navin Ray, Fowzul Islam Fahad, Arulkumar Nagappan, Sayan Deb Dutta and Raj Kumar Mongre
Onco 2025, 5(2), 27; https://doi.org/10.3390/onco5020027

Comprehensive Analysis of Advancement in Optical Biosensing Techniques for Early Detection of Cancerous Cells
by Ayushman Ramola, Amit Kumar Shakya and Arik Bergman
Biosensors 2025, 15(5), 292; https://doi.org/10.3390/bios15050292

Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies
by Valencia Mc Neil and Seung Won Lee
Cancers 2025, 17(9), 1408; https://doi.org/10.3390/cancers17091408

Prunin: An Emerging Anticancer Flavonoid
by Juie Nahushkumar Rana and Sohail Mumtaz
Int. J. Mol. Sci. 2025, 26(6), 2678; https://doi.org/10.3390/ijms26062678

Advancing Cancer Therapy with Quantum Dots and Other Nanostructures: A Review of Drug Delivery Innovations, Applications, and Challenges
by Ashutosh Pareek, Deepanjali Kumar, Aaushi Pareek and Madan Mohan Gupta
Cancers 2025, 17(5), 878; https://doi.org/10.3390/cancers17050878

From Bench to Bedside: Transforming Cancer Therapy with Protease Inhibitors
by Alireza Shoari
Targets 2025, 3(1), 8; https://doi.org/10.3390/targets3010008

Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
by Tânia Moura, Paula Laranjeira, Olga Caramelo, Ana M. Gil and Artur Paiva
Curr. Oncol. 2025, 32(3), 143; https://doi.org/10.3390/curroncol32030143

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
by Jennifer Haynes and Prasath Manogaran
Int. J. Mol. Sci. 2025, 26(5), 1988; https://doi.org/10.3390/ijms26051988

Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms
by Neha Singaravelan and Trygve O. Tollefsbol
Nutrients 2025, 17(4), 616; https://doi.org/10.3390/nu17040616

Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
by Fatih Ciftci, Ali Can Özarslan, İmran Cagri Kantarci, Aslihan Yelkenci, Ozlem Tavukcuoglu and Mansour Ghorbanpour
Pharmaceutics 2025, 17(1), 121; https://doi.org/10.3390/pharmaceutics17010121

 

Genetic and Epigenetic Analyses in Cancer
Guest Editor: Prof. Dr. Jing Gong
Deadline for manuscript submissions: 20 April 2026

Improving the Quality of Life in Patients with Gynecological Cancer
Guest Editor: Dr. Vasilios Pergialiotis
Deadline for manuscript submissions: 20 May 2026

Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment
Topic Editors: Dr. Won Sup Lee, Prof. Dr. Yaewon Yang and Prof. Dr. Seil Go
Deadline for manuscript submissions: 31 July 2026

Advances in Implementation Science and Knowledge Mobilization for Cancer Control
Guest Editor: Dr. Sarah Neil-Sztramko
Deadline for manuscript submissions: 31 August 2026

3 February 2026
Acknowledgment to the Reviewers of Biosensors in 2025


The editorial office of Biosensors would like to extend its sincere gratitude to all reviewers who contributed to the improvement of the journal quality by providing their expert opinion and evaluation of the submitted research.

We appreciate that thorough peer review demands considerable time and intellectual investment from our reviewers. In 2025, Biosensors received 3941 review reports from contributors across 67 countries and territories, demonstrating the breadth of international expertise and scholarly engagement that has strengthened our publication standards. 

The reviewers who agreed to have their names published this year are listed below in alphabetical order by first name. The editorial team acknowledges with gratitude all reviewers, named and anonymous alike, for their vital role in maintaining the scholarly standards of Biosensors.

Abdellatif Ait Lahcen Marcin Szalkowski
Abderrahim Yassar Marco Giannetto
Abdul Rahaman Wahab Sait Marco Girolami
Adem Ozcelik Marco Grossi
Aditya Ashok Marco Travagliati
Adriana Cambón Maria Argyro Karageorgou
Akhilesh Kumar Gupta María Begoña González-García
Akhmad Irhas Robby María Carolina Talio
Alap Ali Zahid Mariagrazia Lettieri
Aleksandra Wierzba María-José Bañuls
Alessandro Sanginario Marioara Avram
Alexey Bogdanov Mark Bradley
Amid Shakeri Marko Jovic
Amin Ebrahimi Martin Silva
Amin Fatoni Max Gong
Amir Hatamie Maxim Kazantsev
Amit Nautiyal Md Ashrafuzzaman
Ana Díaz-Fernández Mengyan Nie
Ana Margarida L. Piloto Meysam Keshavarz
Ana Maria Manea-Saghin Miao Tang
Ana Patrícia Carapeto Michael Santillo
Anabel Lostao Michael Zieger
Anatoly V. Zherdev Miguel Fernandes
Andreas Tsakalof Mikhail N. Ryazantsev
Andris Anspoks Milica Jovic
Andrzej Kudelski Mingcen Weng
Angel Guillermo Bracamonte Mingpeng Yang
Anthony Watkins Miroslav Pohanka
Antonella Virgilio Mohammad Afsar Uddin
Antonio Tempone Mohammad Reza Raveshi
Aranzazu Narvaez Mostafa Shooshtari
Arash Mohammadinejad Muhammad Ali Butt
Arghya Sett Muhammad Asad Ullah Khalid
Arianna Trettel Muhammad Asghar Khan
Arnaldo César Pereira Muhammad Iqhrammullah
Arpana Parihar Muthaiah Shellaiah
Arpita Roy Myung-suk Chun
Arvind Mukundan Nae Yoon Lee
Ashutosh Kumar Naeem Akhtar
Asmaa Farahat Nalin Maniya
Avishek Das Nan Zhao
Aydin Bordbar-Khiabani Nandhinee Radha Shanmugam
Aymen Flah Nasa Savory
Banggee Hsu Natalia Komarova
Barbara Palys Natassa Pippa
Bargel Hendrik Neftali Nuñez
Bartosz Janaszek Nélia Alberto
Belhoussine Drissi Taoufiq Nenghui Zhang
Bernhard Schwaberger Nidhi Nandu
Bhasker Radaram Nikolaos Kourkoumelis
Bin Ai Ning Xu
Binfeng Yin Nino F. Läubli
Bo Zheng Nítalo André Farias Machado
Braulio Cardenas-Benitez Nomin-Erdene Oyunbaatar
Brian Birch Nuria López Ruiz
Brian J. de la Franier Oleg A. Shlyakhtin
Bruno Miranda Olga Kamanina
Carlo Camerlingo Önder Mehmet Pekcan
Carlos G. Juan Ongard Thiabgoh
Chen Ye Osman Erogul
Chenhui Yang Ozren Gamulin
Chenyu Tang Paolo Bertoncello
Chiara Zanardi Paolo Crippa
Christabel Tan Paolo Marconcini
Christopher Pöhlmann Pargam Vashishtha
Christos Spandonidis Patrycja Suchorska-Woźniak
Claudia Cirillo Paula Ferreira
Colin K. Drummond Pedro D. Vaz
Cristhian Berríos Pedro Faia
Damir Iveković Pellegrino La Manna
Dana Baum Pengfei Jia
Dania Gutiérrez Phuong Thy Nguyen
Daniele Funaro Piotr Borowik
Danny K. Y. Wong Pramod Kumar Gupta
Daodao Hu Přemysl Lubal
Dapeng Li Przemyslaw Tomasik
Daqing Piao Qi Zeng
Davide Ferraro Qiangyuan Zhu
Davide Rocco Quandong Huang
Deepak Berwal Radoslaw Bednarek
Devesh U. Kapoor Rafiq Ahmad
Dinakaran Thirumalai Rajendra Dhakal
Dirk Tuma Rakesh Rajaboina
Dmitrii Pankratov Ramalingam Manikandan
Dmitry Petrov Reza Abbasi
Dmitry Samigullin Riccardo Corpino
Dong Kee Yi Roald M. Tiggelaar
Donghwi Cho Rodrigo Pessoa
Dumith Jayathilaka Roopkumar Sangubotla
Dumitru Popovici Rudy Luck
Eduard Llobet Rui Jia
Ejaz Hussain Rui Vilao
Ekaterina I. Khamzina Sabari Arul Narayanasamy
Elena Dilonardo Samar Singh Sandhu
Elena Polisadova Sameer Hussain
Elena Zavyalova Samy Emara
Elida Nora Ferri Sangho Bok
Elisabetta Profumo Sanju Gupta
Elshymaa A. Abdelnaby Savvas Georgiades
Emiliano Martínez-Periñán Scott Crawford
Emmanuel Topoglidis Seeni Meera Kamal Mohamed
Enrico Feltresi Selcan Karakuş
Ergun Alperay Tarim Sergey Ivashov
Erin Patrick Serguei Stoukatch
Federico Tommasi Serkan Demirci
Fei Han Shakira Ghazanfar
Fei Yan Shatrudhan Palsaniya
Fereshteh Vajhadin Shengchun Hung
Francesco Arcadio Shengxuan Xia
Francisco Armijo Shengyuan Deng
Frederic Melin Shimshon Belkin
Gi-Ja Lee Shofarul Wustoni
Gabriela Figueroa Miranda Shuai Chen
Gabriela Valdes Ramirez Shuo Yin
Ganesh Pattan Siddappa Sibel Buyuktiryaki
Gaulthier Rydzek Sina Kheiri
Geer Teng Soichi Yabuki
Georg Fischer Sonia Freddi
George Tsogkas Sonia Kotowicz
Gerald Audette Stefania Dello Iacono
Gesmi Milcovich Stefano Luin
Giaan Arturo Álvarez-Romero Stephen Rathinaraj Benjamin
Gianluca Trotta Subhajit Chakraborty
Gianmarco Lazzini Sudeep Sharma
Gintautas Bagdziunas Sulakshana Shenoy
Giorgia Fiori Süleyman Aşır
Giuseppina Carla Gini Sumedha Nitin Prabhu
Gloria Verónica Vázquez Sung-min Kang
Gregor Marolt Sungwan Kim
Grigor B. Bantchev Supriya Atta
Guangtao Zan Surjendu Maity
Guiqiang Wang Susana de Marcos
Haifeng Ling Susana O. Catarino
Haiwei Ji Susanna Spinsante
Hamada A. A. Noreldeen Taihong Liu
Hannaneh Hojaiji Takashi Matsumoto
Haotian Cha Tales Cleber Pimenta
Harsh Kumar Tanmay Kulkarni
Helmut Telle Tao Yang
Hem Joshi Tatiana Rusanova
Hiroshi Aoki Teresa Basinska
Huamin Chen Teresa Cuberes
Hyusein Yemendzhiev Thenmozhi Rajarathinam
Ibrahim Abdulhalim Thomas Blaudeck
Igor Buzalewicz Tianjia Yang
Ioannis A. Tsakmakidis Tianyu Jiang
Irena Ivanišević Tifeng Jiao
Irene Ojeda Tine Hansen
Irina Yu Goryacheva Tirayut Vilaivan
Iryna Soltys Todor Stoilov Todorov
James Knox Russell Trieu Nguyen
Jan Macutkevic Umamaheswari Rajagopalan
Jasmine Devadhasan Valentina Bello
Jasneet Grewal Vijay Bhooshan Kumar
Jason Baardsnes Viktor Dremin
Jeewan Chaminda Ranasinghe Vilma Ratautaite
Jerome Ferrance Vishakha Vishram Tambe
Jesús Antonio Cruz Navarro Vladimir Mirsky
Jian Wu Vojko Jazbinšek
Jiangjiang Zhang Waldemar Alejandro Marmisollé
Jiangtao Huangfu Walter Buchwald
Jiangyu Zhu Waseem Jerjes
Jianting Zhu Wei Du
Jijun Feng Wei Ling
Jimin Lee Wen Chen
Jincheng Xiong Wendong Wang
Jingjing Zhang Wenxin Fan
Jinjun Xia William Edward Lee
Jinrun Liu Williamson Gustave
Joanna Sekulska-Nalewajko Xiao Fan
Johann Köhler Xiaodong Zhou
John S. Mitchell Xiaojia Jin
Jonathon Olesberg Xin Cui
José A. Saéz Cases Xiuzhong Wang
Jose Artur Brito Xuechao Xu
José M. Olmos Yalei Hu
Joshua Lee Yan Zhang
Juan Allegretto Yanan Huang
Juan David Ospina-Villa Yanfeng Gao
Junhui Hu Yang-Wei Lin
Kai Song Yanlei Li
Kavirajaa Pandian Sambasevam Yantao Xing
Ki Soo Park Yao Ni
Koyappayil Aneesh Yasuo Terasawa
Krishnamoorthy Sathiyan Yifeng Hong
Krzysztof Kruczala Yihao Chen
Kun Wang Ying Mu
Lanying Li Yiwei Xu
László Péter Youjun Zeng
Laura Sutarlie Yue Zhang
Lea Spindler Yuki Hashimoto
Ling Ma Yulia G. Mourzina
Lluís A. Belanche Muñoz Yuliy Bludov
Lorena Mardones Yun Shan
Lu Miao Yunfeng Wu
Luca De Stefano Yuting Wu
Lucia Sarcina Yuxin Zhang
Luděk Havran Zhao Huang
Luigi Campanella Zhen Qin
Luigi Ranno Zhiyong Ni
Madhusudan Kulkarni Zhongqiang Luo
Maheshwaran Selvarasu Zhu Chen
Manuel Reis Carneiro Zhuomin Zhang
Marcello Berto Zijian Wan
Marcin Jesionek Zorica Mojović

2 February 2026
MDPI INSIGHTS: The CEO's Letter #31 - MDPI 30 Years, 500 Journals, UK Summit, Z-Forum Conference, APE

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI at 30: Three Decades of Open Science, Built Together

As we begin 2026, we approach a meaningful milestone in MDPI’s history: 30 years of advancing Open Science.

What began in 1996 as a small, researcher-driven initiative has grown into a global open-access publisher, supporting hundreds of journals, millions of researchers, and a shared belief that scientific knowledge should be openly available to all. Over these three decades, Open Access has moved from the margins to the mainstream, and MDPI has been proud to help shape that transformation.

To mark this anniversary year, we are pleased to share our MDPI 30th Anniversary logo.

The Anniversary logo is intentionally simple, confident, and enduring, designed to work across cultures, disciplines, and digital environments. It reflects both continuity and progress, honouring MDPI’s established identity while representing the company we are today. The green accent symbolizes our connection to the research communities we serve and the collaborative nature of Open Science itself.

Alongside the visual identity, we are also introducing our 30th Anniversary tagline:

30 Years of Open Science, Built Together.

This phrase captures what has always defined MDPI. Open Science is not the work of a single organization: it is a collective effort shaped by researchers, editors, reviewers, institutions, and the many teams who support the publishing process every day. MDPI’s role has been to provide the infrastructure and commitment that allow this collaboration to thrive.

Throughout 2026, we will mark this anniversary through regional events, global conversations, and editorial initiatives that reflect on MDPI’s evolution, its impact across disciplines, and the communities that make this work possible.

“Open Science is a collective effort”

Whether you have been part of MDPI’s journey for decades or are engaging with us for the first time this year, this milestone belongs to all of us. The past 30 years have shown what is possible when openness, trust, and collaboration are placed at the centre of scholarly communication.

As we look ahead, our focus remains clear: continuing to strengthen quality, integrity, and partnership – so that Open Science can keep moving forward, together.


Impactful Research

A Shared Milestone: MDPI’s Journal Portfolio Reaches 500 Titles

MDPI has reached an important milestone: our journal portfolio grew to more than 500 academic journals last year, spanning the fields of chemistry, engineering, biology, medicine, environmental sciences, the social sciences, and beyond.

The number itself is significant, but what matters more is what supports it: hundreds of scholarly communities that have chosen to collaborate, grow, and publish with MDPI.

From our beginnings nearly 30 years ago with a single Open Access journal (Molecules), MDPI has been guided by a simple aim: advancing Open Science. Reaching 500 journals is not an endpoint. It reflects the diversity of disciplines, ideas, and research cultures that now form part of our shared ecosystem. 

Growth with Purpose

Every journal exists because a specific community believes there is a need for focus, visibility, and dialogue in a particular field. As our portfolio has expanded, so has our responsibility to ensure that scale is matched with strong editorial standards, robust research integrity practices, and meaningful academic leadership.

This milestone comes as we enter MDPI’s 30th anniversary year, a fitting moment to reflect on what scale in scholarly publishing truly requires: not only reach, but also dedicated long-term stewardship.

New Journals, New Communities

In December 2025 alone, MDPI welcomed eight newly launched journals and three journal transfers (details below), all of which published their inaugural issues by year-end.

Each of these journals is shaped by its Editors-in-Chief, Associate Editors, and Editorial Board Members, who define its scope, standards, and direction. We are grateful for the time, expertise, and commitment they bring to building these new communities.

Welcoming Transferred and Acquired Journals

We were pleased to publish the first MDPI issues of three recently transferred or acquired journals:

  • Cardiovascular Medicine – advancing research on the prevention, diagnosis, and treatment of cardiovascular disease
  • Germs – addressing infectious diseases through clinical, public health, and translational perspectives
  • Romanian Journal of Preventive Medicine (RJPM) – supporting population health, early detection, and preventive care in collaboration with the Romanian Society of Preventive Medicine

Each of these journals brings an established identity and legacy. Our role is to support their continued development with the same editorial rigor, transparency, and Open Access principles that guide our broader portfolio.

A Collective Achievement

Reaching more than 500 journals is not the achievement of any single team or individual. It is the result of collaboration across the entire scholarly ecosystem. As such, I would like to thank our authors, reviewers, academic editors, and Editorial Board Members, as well as our colleagues across MDPI, who support these communities every day.

As we look ahead, we will continue to expand the breadth and depth of our publishing activities while remaining attentive to the evolving expectations of Open Science, research integrity, and responsible growth.

This milestone is a reminder that Open Access publishing is not only about making research available. It is about building platforms where knowledge can be shared, challenged, improved, and trusted, at scale, and with care.

Inside Research

MDPI UK Summit 2026 in Manchester (21–22 January)

On 21–22 January, we had the pleasure of hosting the MDPI UK Summit 2026 in Manchester. Over two days, we welcomed more than 20 Editors-in-Chief (EiC), Section Editors-in-Chief (SEiC), and Associate Editors for an open, in-depth conversations about how MDPI supports Open Science, editorial independence, and research standards across our journals. 

What stood out most was not just the quality of the discussions, but the openness, curiosity, and mutual respect that shaped every session.

What We Covered 

The programme was designed to give insight into how MDPI works behind the scenes and how different teams collaborate to support our journals and editors. Topics included:

  • MDPI overview and the evolving Open Access market
  • MDPI–UK collaboration and local engagement
  • Editorial and peer-review processes
  • Research integrity and publication ethics
  • Institutional partnerships
  • Indexing, journal development, and academic community engagement

Sessions were led by MDPI colleagues across editorial, research integrity, indexing, partnerships, and UK operations, showing how cross-functional our work truly is. 

What We Heard

The feedback from editors was both encouraging and grounding:

  • 92% rated the Summit Excellent (8% Good)
  • 100% said their understanding of MDPI’s values, editorial processes, and local collaborations had significantly improved
  • 69% attended primarily to stay informed about academic publishing and research integrity
  • 85% felt fully heard and engaged

A few comments that stayed with me:

  • “Today’s event truly gave me the opportunity to see the heart of MDPI UK.”
  • “The summit was very informative – I really enjoyed seeing the behind-the-scenes operations.”
  • “Keep being open to discussions and making editors feel part of the MDPI family.”

These reflections remind us that transparency, listening, and dialogue are not nice-to-haves: they are foundational to trust.

Looking Ahead

The UK Summit is one of more than 10 MDPI Summits we are organizing this year across North America, Europe, and APAC. Each one is an investment in relationships, shared understanding, and improvement.

Thank you to the MDPI UK team and supporting colleagues across departments who made this event possible. This was a positive step in strengthening our editorial engagement and kicking off a year of MDPI Summits.

Coming Together for Science

Recapping the Z-Forum 2026 Conference on Sustainability and Innovation (15–16 January 2026)

In January, MDPI supported and participated in the Z-Forum on Sustainability and Innovation, held across Zurich (ETH Zurich) and the city of Baden. With 96 participants and more than 30 speakers and panellists, the forum brought together leaders from government, academia, industry, and innovation ecosystems to explore how sustainability, Open Science, and innovation intersect in practice.

Why this mattered for MDPI

As a Swiss-based publisher with global reach, our investment in Z-Forum reflects a strategic intent: to anchor MDPI more deeply within Swiss research networks while contributing to national and international conversations on sustainability and innovation.

This was not only about visibility; it was also about relationship-building and long-term engagement with institutions shaping research policy and practice in Switzerland.

High-level participation and credibility

The forum was supported and sponsored by several key Swiss institutions, including:

  • The Swiss National Science Foundation (SNSF) – Switzerland’s central research funding body
  • ETH Zurich
  • The University of Zurich
  • The University of Basel
  • Swiss Innovation Park Central

The sponsorship of SNSF lent the forum strong institutional credibility and signalled the relevance of the themes discussed, especially around sustainability, innovation frameworks, and responsible research practices.

Beyond the Room: Extending the Conversation

While attendance was intentionally focused to encourage dialogue, the forum’s reach extended well beyond the venue. Multiple LinkedIn posts before and during  the event (e.g., Link 1, Link 2, Link 3, and more) built on the discussions and helped position MDPI as an active and credible contributor within Switzerland’s research and innovation landscape.

A Broader Strategic Signal

Z-Forum is part of a wider effort to:

  • Build on MDPI’s Swiss institutional relationships
  • Reinforce our leadership in Open Science and sustainability
  • Engage proactively with funders, universities, and innovation bodies
  • Ensure MDPI remains a visible and constructive partner in the ecosystems where research policy and practice are shaped

Thank you to our Conference team and everyone involved in supporting this event, both behind the scenes and on the ground. These moments of engagement may be small in scale, but they are foundational in impact.

Closing Thoughts

Reflections from the Academic Publishing in Europe Conference

During 13-14 January, I attended the Academic Publishing in Europe (APE) Conference in Berlin, a long-standing forum for discussing scholarly publishing and the deeper principles that support it.

MDPI was proud to be a Gold Sponsor of the 20th Anniversary of the APE conference, reflecting our continued commitment to supporting the scholarly community to engage in critical industry discussions.

This year’s program covered a range of topics, from AI and research integrity to policy, infrastructure, and trust, but one theme stood out clearly for me: academic freedom, and what it means to protect the conditions under which knowledge can be produced, evaluated, and shared responsibly.

Before turning to that, I would like to highlight the opening keynote by Carolin Sutton (CEO, STM), which helped set the tone for the conference.

An Independent Publishing Industry: The Case for Checks and Balances

In her opening remarks, Carolin focused on the importance of continually evolving systems of checks and balances, both operationally and at the marketplace level, to prevent any single actor from dominating knowledge production. Her framing emphasized shared responsibility across publishers, institutions, and research communities, rather than placing the burden on any one group.

As part of this, she revisited the work of sociologist Robert K. Merton, and his CUDOS norms of scientific ethos, first articulated in his 1942 work, The Normative Structure of Science.

Merton outlined four ideals that support healthy scientific systems:

  1. Communalism – knowledge as a public good
  2. Universalism – evaluation based on merit, not status or identity
  3. Disinterestedness – orientation toward truth over personal or financial gain
  4. Organized Skepticism – systematic, critical scrutiny of claims

While these are ideals, and not guarantees that are perfectly lived up to, they remain powerful reference points today for research systems and organizations as they aim to grow and scale.

It was interesting to see how closely these norms align with foundational principles of Open Access. For example, making research openly available supports communalism. Transparent peer review and editorial processes reinforce universalism and organized skepticism. Strong ethics frameworks and governance help counter conflicts of interest and support disinterestedness.

“Merton’s ideals remain powerful reference points today”

 Safeguarding Research: Academic Freedom

Several of the conference sessions touched on the pressures faced by researchers, editors, and institutions: geopolitical tensions, online harassment, misinformation, reputational risk, shrinking resources, and politicized narratives around science.

“Integrity is not static. It must be actively maintained as systems grow.”

A particularly timely presentation came from Ilyas Saliba, who talked about academic freedom. His remarks resonated strongly and underlined the fact that safety in academia is not only physical or digital, but also intellectual.

Academic freedom means safeguarding the ability to ask difficult questions, challenge consensus, publish negative or unexpected results, and participate in scholarly debate without fear of undue personal, political, or commercial consequences. These discussions were a reminder that publishers play an important role in supporting the integrity, accessibility, and credibility of scholarly knowledge, particularly as researchers and institutions face mounting external pressures.

Looking Ahead

The discussions at APE reminded me that integrity is not static. It must be actively maintained as systems grow, expectations evolve, and pressures increase. This applies equally to research integrity, academic freedom, and the broader trust placed in scholarly communication.

I left APE encouraged by the openness of the dialogue and the willingness across publishers, institutions, and communities to engage with difficult questions rather than avoid them. Forums like this play a pivotal role in helping our industry pause, reflect, and recalibrate.

As MDPI continues to grow and as we enter our 30th anniversary, these conversations remind me of the core purpose of science: advancing knowledge for the benefit of society.

Stefan Tochev
Chief Executive Officer
MDPI AG

22 January 2026
Biosensors | Highly Cited Papers from 2024–2025 in Web of Science


We are delighted to present, from the highly cited papers in the Web of Science from 2024 and 2025, a curated list of high-quality articles from Biosensors (ISSN: 2079-6374), as shown below.

1. “AI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring”
by Tomasz Wasilewski, Wojciech Kamysz and Jacek Gębicki
Biosensors 2024, 14(7), 356; https://doi.org/10.3390/bios14070356
Available online: https://www.mdpi.com/2079-6374/14/7/356 

2. “Advances in Wearable Biosensors for Healthcare: Current Trends, Applications, and Future Perspectives”
by Dang-Khoa Vo and Kieu The Loan Trinh
Biosensors 2024, 14(11), 560; https://doi.org/10.3390/bios14110560
Available online: https://www.mdpi.com/2079-6374/14/11/560

3. “Terahertz Metamaterials for Biosensing Applications: A Review”
by Wu Zhang, Jiahan Lin, Zhengxin Yuan, Yanxiao Lin, Wenli Shang, Lip Ket Chin and Meng Zhang
Biosensors 2024, 14(1), 3; https://doi.org/10.3390/bios14010003
Available online: https://www.mdpi.com/2079-6374/14/1/3

4. “Surface Plasmon Resonance-Based Biodetection Systems: Principles, Progress and Applications—A Comprehensive Review”
by Muhammad A. Butt
Biosensors 2025, 15(1), 35; https://doi.org/10.3390/bios15010035
Available online: https://www.mdpi.com/2079-6374/15/1/35 

5. “MXene-Based Electrochemical Biosensors: Advancing Detection Strategies for Biosensing (2020–2024)”
by Chaudhery Mustansar Hussain and Joydip Sengupta
Biosensors 2025, 15(3), 127; https://doi.org/10.3390/bios15030127
Available online: https://www.mdpi.com/2079-6374/15/3/127 

6. “Exploring Innovative Approaches for the Analysis of Micro- and Nanoplastics: Breakthroughs in (Bio)Sensing Techniques”
by Araceli Sánchez-Álvarez, Denise Margarita Rivera-Rivera, Donato Luna-Moreno, Erika Iveth Cedillo-González, Gabriela Elizabeth Quintanilla-Villanueva, Garima Kaushik, José Manuel Rodríguez-Delgado, Juan Francisco Villarreal-Chiu and Melissa Marlene Rodríguez-Delgado
Biosensors 2025, 15(1), 44; https://doi.org/10.3390/bios15010044
Available online: https://www.mdpi.com/2079-6374/15/1/44

7. “Next-Generation Potentiometric Sensors: A Review of Flexible and Wearable Technologies”
by Mahmoud Abdelwahab Fathy and Philippe Bühlmann
Biosensors 2025, 15(1), 51; https://doi.org/10.3390/bios15010051
Available online: https://www.mdpi.com/2079-6374/15/1/51

8. “Integration of Functional Materials in Photonic and Optoelectronic Technologies for Advanced Medical Diagnostics”
by Laxmi Bugude, Naveen Thanjavur and Young-Joon Kim
Biosensors 2025, 15(1), 38; https://doi.org/10.3390/bios15010038
Available online: https://www.mdpi.com/2079-6374/15/1/38

Back to TopTop